These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
530 related items for PubMed ID: 30619241
1. The Development of Whole Sporozoite Vaccines for Plasmodium falciparum Malaria. Itsara LS, Zhou Y, Do J, Grieser AM, Vaughan AM, Ghosh AK. Front Immunol; 2018; 9():2748. PubMed ID: 30619241 [Abstract] [Full Text] [Related]
2. Exploring immunological mechanisms of the whole sporozoite vaccination against P. falciparum malaria. Mo AX, Pesce J, Hall BF. Vaccine; 2015 Jun 09; 33(25):2851-7. PubMed ID: 25917675 [Abstract] [Full Text] [Related]
3. Development of whole sporozoite malaria vaccines. Hollingdale MR, Sedegah M. Expert Rev Vaccines; 2017 Jan 09; 16(1):45-54. PubMed ID: 27327875 [Abstract] [Full Text] [Related]
4. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens. Bettencourt P. Front Immunol; 2020 Jan 09; 11():190. PubMed ID: 32153565 [Abstract] [Full Text] [Related]
5. Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites. Atre T, Robinson TM, Savransky T, Dutta S, Epstein JE, Bergmann-Leitner ES. Malar J; 2019 May 29; 18(1):186. PubMed ID: 31142328 [Abstract] [Full Text] [Related]
6. Live attenuated pre-erythrocytic malaria vaccines. Keitany GJ, Vignali M, Wang R. Hum Vaccin Immunother; 2014 May 29; 10(10):2903-9. PubMed ID: 25483648 [Abstract] [Full Text] [Related]
7. The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review. Epstein JE, Richie TL. Curr Opin Infect Dis; 2013 Oct 29; 26(5):420-8. PubMed ID: 23982233 [Abstract] [Full Text] [Related]
8. The march toward malaria vaccines. Hoffman SL, Vekemans J, Richie TL, Duffy PE. Vaccine; 2015 Nov 27; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116 [Abstract] [Full Text] [Related]
11. Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial. Walk J, Reuling IJ, Behet MC, Meerstein-Kessel L, Graumans W, van Gemert GJ, Siebelink-Stoter R, van de Vegte-Bolmer M, Janssen T, Teelen K, de Wilt JHW, de Mast Q, van der Ven AJ, Diez Benavente E, Campino S, Clark TG, Huynen MA, Hermsen CC, Bijker EM, Scholzen A, Sauerwein RW. BMC Med; 2017 Sep 13; 15(1):168. PubMed ID: 28903777 [Abstract] [Full Text] [Related]
12. Novel ELISA method as exploratory tool to assess immunity induced by radiated attenuated sporozoites to decipher protective immunity. Knepper TA, Duncan EH, Savransky T, Bergmann-Leitner ES. Malar J; 2017 Nov 29; 16(1):484. PubMed ID: 29187199 [Abstract] [Full Text] [Related]
13. Quantification of Plasmodium knowlesi versus Plasmodium falciparum in the rhesus liver: implications for malaria vaccine studies in rhesus models. Shears MJ, Seilie AM, Kim Lee Sim B, Hoffman SL, Murphy SC. Malar J; 2020 Aug 31; 19(1):313. PubMed ID: 32867784 [Abstract] [Full Text] [Related]
18. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hoffman SL, Billingsley PF, James E, Richman A, Loyevsky M, Li T, Chakravarty S, Gunasekera A, Chattopadhyay R, Li M, Stafford R, Ahumada A, Epstein JE, Sedegah M, Reyes S, Richie TL, Lyke KE, Edelman R, Laurens MB, Plowe CV, Sim BK. Hum Vaccin; 2010 Jan 31; 6(1):97-106. PubMed ID: 19946222 [Abstract] [Full Text] [Related]